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Delirium is a disorder of cerebral dysfunction, frequently encountered 
in acutely ill patients, and especially among elderly patients. The 
Diagnostic and Statistical Manual of Mental Disorders, 5th  edition 
(DSM-5) considers the following features diagnostic of delirium: 
‘disturbance in attention and awareness; disturbance in cognition 
and higher functioning; a short onset and fluctuating course; a 
clear precipitant must be identified, whether an acute illness, drug 
intoxication or withdrawal; with no other neurocognitive disorder 
identified to account for presentation’.[1,2] Many precipitating factors 
for delirium have been described, including neurological conditions, 
local and systemic sepsis, metabolic derangements, pain and iatrogenic 
interventions (e.g. surgical procedures and catheterisation). Premorbid 
cognitive dysfunction is an important risk factor.[3-7]
Delirium is common among medical inpatients, with rates of 11 - 
42%.[3,7-9] A higher prevalence is found among geriatric populations[10,11] 
and in intensive care units.[12] There are very few studies of delirium 
in unselected patients, particularly in low- and middle-income 
countries (LMICs) undergoing epidemiological transitions, where 
there may be a greater burden of infectious disease, including HIV, 
and relatively younger age of onset of non-communicable diseases 
(NCDs). A 2015 systematic review on delirium in sub-Saharan Africa 
described the scarcity of literature, with reported cohorts being 
very small; there were also technical difficulties with regard to 
terminology, diagnostic criteria and reporting of these studies. In 
contrast to high-income countries, patients were younger and more 
likely to have infectious precipitants.[13] 
Delirium has been associated with adverse outcomes, including 
longer hospital stay, higher rates of readmission, and increased short- 
and long-term mortality. Consequently, there are greater individual, 
social and monetary implications associated with delirium.[3,8,14-22] 
Early management of the condition has been associated with shorter 
delirium duration and hospital length of stay, as well as improved 
functional outcomes.[23,24] Recognition of risk factors is an important 
aid in the prevention of incident delirium. Measures to improve 
assessment and management may have benefits in terms of improving 
healthcare for inpatients,[25,26] and incident delirium is used as part of 
quality assurance in many hospitals. Nevertheless, delirium is often 
undiagnosed in busy clinical settings.[27] 
We therefore aimed to describe the prevalence, risk factors and 
short- and long-term outcomes for patients admitted with delirium to 
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Background. Delirium is a common, serious, underdiagnosed condition in medical and surgical inpatients with acute conditions. It is 
associated with increased risk of mortality and morbidity. Data of geriatric cohorts are largely limited to developed countries.
Objectives. To describe prevalence, risk factors and outcomes of delirium among general medical patients admitted to two hospitals in 
Cape Town, South Africa. 
Methods. This was a prospective cohort study of patients with acute conditions admitted to a general medical inpatient service in 
secondary- and tertiary-level public hospitals in the Metro West area of Cape Town. Patients ≥18 years of age were recruited daily from all 
acute medical admissions. Patients were excluded if they were aphasic or their Glasgow coma scale was <8/15. Delirium was diagnosed using 
the validated confusion assessment method (CAM) tool and performed by trained neuropsychologists. Demographic data were collected by 
a clinical team and short- and long-term mortality data were obtained using linkage analysis of hospitalised patients and routinely collected 
provincial death certification records. 
Results. The median age of inpatients was 51 (interquartile range 36 - 65) years, 29% were HIV-infected and the overall prevalence of 
delirium was 12.3%. Multivariate predictors of delirium included the presence of an indwelling urinary catheter (odds ratio (OR) 4.47; 
confidence interval (CI) 2.43 - 8.23), admission with a central nervous system disease (OR 4.34; CI 2.79 - 7.90), pre-existing cognitive 
impairment (OR 3.02; CI 1.22 - 7.43) and immobility (OR 1.88; CI 1.01 - 3.51). HIV infection was not associated with increased risk of 
delirium. Delirium was associated with an increased risk of inhospital (delirium v. no delirium: 29% v. 12%; p<0.01) and 12-month (30% v. 
20%; p<0.01) mortality, as well as increased length of hospital stay (7 days v. 5 days; p<0.01).
Conclusions. In this cohort of medical inpatients (relatively young and with a high HIV prevalence) 1 of 8 (12.3%) patients was delirious. 
Delirium was associated with adverse outcomes. Delirium risk factors in this young cohort were similar to those in geriatric cohorts in 
developed countries, and neither HIV nor opportunistic infections increased risk.
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the acute medical service of two public hospitals in Cape Town, South 
Africa (SA). Such knowledge would provide much-needed data from 
an LMIC with a high background prevalence of HIV and NCDs.
Methods
Study design and setting
This was a prospective cohort study of patients admitted with acute 
medical conditions from 11 November 2013 to 7 April 2014 at two 
university-affiliated hospitals serving the Metro West area of Cape 
Town. Groote Schuur Hospital has ~120 acute-care medical beds and 
serves as a tertiary referral centre; the majority of patients with acute 
conditions are, however, admitted from the emergency department as 
‘walk-ins’– a minority are referred from other hospitals in the area for 
more specialised care. Victoria Hospital, a district-level hospital, has 
80 acute-care medical beds. Patients with acute conditions are largely 
admitted to undifferentiated general medical wards under a single 
specialist consultant-run team.
Participants
In this prospective observational study up to 10 randomly selected 
patients of the daily weekday acute medical intake were reviewed 
for study inclusion by a team of 2 trained clinicians at each hospital 
during consecutive 3-month periods (November - January in the first 
hospital and February - April in the second hospital). All patients 
aged ≥18 years and admitted for the first time during this period as 
acute, non-elective patients to the general medical wards could be 
included. Patients refusing consent, those not available in the ward 
on the day of sampling, those who died before the day of sampling 
and those with aphasia or a Glasgow coma scale (GCS) <12/15 were 
excluded. 
Delirium assessment
Within 24 hours of admission, a study physician reviewed the 
patients’ charts and obtained data pertaining to their primary 
diagnosis, clinical background, admission medication, level of 
education and demographic characteristics. An independent study 
neuropsychologist then assessed the patient for delirium, using 
the confusion assessment method (CAM) performed during a 20 - 
30-minute interview, consisting of formal cognitive testing, and also 
assessed delirium in conjunction with the physician according to the 
Diagnostic and Statistical Manual of Mental Disorders, 4th  edition 
(DSM-IV) criteria. For all testing tools, the language barrier was 
noted; a ward-based translator was engaged when possible, so that 
testing was performed in the patient’s first language. 
Demographic data, presenting complaint, primary admission 
diagnosis and potential associates of delirium available from routine 
assessment were obtained from the patient, relatives and referring 
physician. Data on pre-admission functional status (in the form of 
the Barthel index of activities of daily living), chronic medications at 
the time of admission, comorbidities and blood results were collected. 
For analysis, we dichotomised laboratory values to clinically valuable 
‘normal’ or ‘abnormal’ results. For serum creatinine, a simple 
round number cut-off of 100 µmol/L was used, signifying renal 
impairment in most people. For serum urea concentration, the upper 
limit of normal (7 mmol/L) was used. Comorbidities were defined 
as any pre-existing medical or surgical condition. Data on HIV 
status, pre-existing cognitive impairment, depression, visual/hearing 
impairment and drug/alcohol abuse were also recorded, where 
available. The clinician recorded whether the patient was suffering 
from a ‘terminal illness’, defined as being in the last year of their 
life. Information on mobility was obtained; immobility was defined 
as a patient not being able to walk independently for >50 metres. 
Pre-existing cognitive impairment was defined as a patient history 
suggesting cognitive decline before admission. Depression was 
defined as a patient history suggesting depressive symptoms prior 
to the current admission. For analysis and reporting, diagnoses were 
categorised as communicable and non-communicable and classified 
into major and common groups, using the International Statistical 
Classification of Diseases and Related Health Problems 10th Revision 
(ICD-10) code grouping.
Outcomes
Length of hospital stay, inpatient mortality and 12-month mortality 
data were obtained from patient folders, the hospital electronic 
patient management system and the Western Cape Government death 
registry, which links a unique patient identification number with 
national death certificate records and system-wide electronic records. 
Patients for whom no death record was available, were deemed ‘alive’.
Statistical methods
All data were analysed using Stata 14 (StataCorp., USA). Categorical 
variables were summarised as frequencies and percentages and 
continuous variables as medians with interquartile ranges (IQRs) if 
non-parametric. Sociodemographic and clinical characteristics and 
outcomes were assessed for differences between those with delirium 
and those without. Associations between categorical variables were 
analysed using the χ2 test and Fisher’s exact test, as appropriate. The 
Wilcoxon rank-sum or Kruskal-Wallis test was used to compare 
continuous variables between two and three groups, respectively. 
Significance was reported as p<0.01, with no correction for multiple 
comparisons.
Univariable and multivariable logistic regression analyses were 
performed to identify risk factors for delirium. Risk factors that 
were strongly associated with delirium in the univariable analysis 
(p<0.05) were retained in a multivariable logistic regression model. 
Terminal illness was removed owing to the low number of cases and 
its negative impact on model fit. Model diagnostics were performed 
and the Hosmer-Lemeshow test was used to determine goodness 
of fit. Kaplan-Meier survival curves for delirious v. non-delirious 
patients were compared using the log-rank test. A p-value of <0.05 
was regarded as statistically significant.
Ethical approval
No patient consent was required. Ethical approval was obtained from 
the Faculty of Health Sciences Human Research Ethics Committee, 
University of Cape Town (ref. no. HREC 532/2017).
Results 
A total of 1 027 patients from all admissions were screened for inclusion 
in the study, of whom 138 were excluded for the following reasons: 
43 had a depressed level of consciousness with a GCS <12/15; 35 were 
not admitted directly into a general medical ward or were transferred 
to another discipline; 47 were aphasic; 2 were deaf and could not be 
tested effectively; and 8 died before testing. A further 84 patients 
were not included in the final analysis: in the case of 49, their data 
were missing, and 35 refused consent. A total of 808 participants were 
included in the analysis. The number of patients enrolled per day 
varied as a percentage of the total admissions owing to the carrying size 
of admissions; the total also varied because of exclusions.
Patient demographics 
The median (IQR) age was 51 (36 - 65) years; only 17.7% of 
participants were >70 years of age. The gender distribution was 
equal, with 52% females. The most frequent admission diagnoses 
521       June 2020, Vol. 110, No. 6
RESEARCH
were NCDs of the cardiovascular (n=170), central nervous (n=86) 
and respiratory (n=76) systems, followed by pulmonary tuberculosis 
(n=60) and non-tuberculous respiratory infections (n=58). The 
majority of patients received chronic medication before admission 
(n=581; 72%), and 29% were using >6 chronic medications.
Delirium prevalence, using either the DSM-IV or CAM reference 
method, was only discrepant in 11 cases; therefore, the results are 
presented using CAM. The overall prevalence of delirium was 12.3%. 
Patients with delirium were older (median age 55 years v. 51 years; 
p=0.03), were more likely to be frail (19% had a pre-admission Barthel 
score of <50) and were more likely to have pre-existing predisposing 
factors, such as cognitive impairment (14%), terminal illness (9%) 
or a urinary catheter at home (30%). The prevalence of infection as 
a primary admission diagnosis was similar in the delirium and non-
delirium cohorts. Patients with delirium were more likely to have 
been admitted primarily because of a neurological disease (Table 1). 
Twenty-nine percent of our cohort were confirmed as being HIV-
infected, with a median (IQR) CD4+ count of 150 (66 - 132) cells/µL. 
The median (IQR) age of HIV-infected patients was lower than that 
of HIV-uninfected patients (36 (30 - 44) v. 52 (38 - 65) years), there 
was a greater female predominance (n=110; 60%) and a different 
profile of primary admission diagnoses, with a predominance of 
communicable diseases. In the HIV-infected cohort, the median 
(IQR) CD4+ count was not significantly lower in patients with 
delirium than in those without (113 (60 - 282) v. 155 (66 - 313) cells/µL; 
p=0.73). In HIV-infected patients the prevalence of delirium was 
13% and did not differ significantly from that in HIV-uninfected 
patients (13% v. 11%; p=0.8). Supplementary Table 1 (http://
www.samj.org.za/public/sup/14363.doc) reports on patients by HIV 
status. 
Predictors of delirium
Table 2 shows univariate and multivariate logistic regression analysis 
of factors associated with delirium. After adjustment for covariates, 
the multivariate predictors of delirium were the presence of an 
indwelling urinary catheter (OR 4.47; CI 2.43 - 8.23), admission 
with a central nervous system disease (OR 4.34; CI 2.79 - 7.90), 
pre-existing cognitive impairment (OR 3.02; CI 1.22 - 7.43) and 
immobility (OR 1.88; CI 1.01 - 3.51). Neither of the following 
were statistically significant in predicting delirium in this cohort: 
HIV status, infection as the admission diagnosis, age, number of 
comorbidities, number of chronic medications or other laboratory 
abnormalities. The goodness-of-fit test of the logistic regression 
equation showed a high significance of the model, with χ2 80.41.
Outcomes
Patients with delirium showed a greater risk for adverse outcomes 
than those without delirium (Table 3). The median length of 
hospital stay was longer (7 days v. 5 days; p<0.01), and inpatient 
mortality (29% v. 12%; p<0.01) and 12-month mortality (30% v. 
20%; p<0.01) were greater. Fig. 1 shows Kaplan-Meier survival 
curves for patients with and without delirium. Survival was 
significantly better without delirium (χ2 7.492; p=0.0062), with the 
majority of differences associated with greater early mortality in 
patients with delirium.
Discussion 
Delirium was common in this young cohort, diagnosed in 1 of 8 patients 
admitted with acute conditions to general medical wards in two 
public-sector hospitals in Cape Town. The predisposing factors for 
delirium were similar to those reported for geriatric cohorts, and 
included premorbid cognitive impairment, a central nervous system 
disease, presence of an indwelling urinary catheter and immobility. 
Despite the high prevalence of HIV, HIV status and HIV-associated 
opportunistic infections were not associated with an increased risk 
of delirium. Delirium at admission was associated with increased 
mortality, predominantly early mortality, although the difference was 
evident up to 12 months after discharge. 
In this study, the overall rate of delirium was 12.3%, i.e. within 
the range reported in the international literature.[3,7-9] Importantly 
though, the composition of this cohort was distinct from that in 
the majority of published reports, and more generalisable to other 
LMICs. A 2006 systematic review by Siddiqi et al.[8] reported on the 
occurrence and outcome of delirium in medical inpatients. In this 
review, the mean age was >70 years in 31 of 33 cohorts, and HIV 
infection rates were not reported in any of the included cohorts. In 
contrast, our median age was 50 years, and our study population 
was unique by virtue of the higher incidence of HIV and HIV-
related illnesses.[28,29] Nonetheless, in our cohort, HIV status was not 
associated with increased risk for delirium. This is in contrast to a 
systematic review by Paddick et al.,[30] who consistently found HIV 
positivity to have a higher association with delirium. 
Study strengths and limitations
The study has several strengths. It was a large prospective study 
among acute general medical admissions in an LMIC. SA’s dual 
burden of communicable disease and NCD makes it an important 
setting in which to consider delirium prevalence, risk factors and 
outcomes.[31] Reference testing was robust – using well-validated 
tools and performed by experienced neuropsychologists. Limitations 
included that only a selection of patients were sampled, with the 
number enrolled per day of the week varying as a total and as a 
percentage of all admissions, which may have led to unanticipated 
confounding. The national death certification records were not 
accessed – patients who moved province and died would therefore 
not have been identified as such. We lacked a very detailed assessment 
of comorbidities, such as the Charlson index or comorbidity-
polypharmacy score. This may have allowed a better understanding 
of the interplay between premorbid functioning, predisposing 
factors, precipitants and development of delirium. We also did 
not capture data on readmission rates and functional status after 
discharge. Such information might have further demonstrated the 
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Fig. 1. Kaplan-Meier survival curves for delirious compared with non-delirious 
patients (p=0.008).
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Western Cape Province has a lower HIV prevalence than most other 
provinces, limiting the total proportion of HIV-infected patients in 
this cohort. 
Conclusions
Our study informs acute general medical practice in LMICs, although 
repeating similar work across the country and in other countries 
would strengthen its findings. Delirium is common in this setting, 
an important predictor of morbidity and mortality. ‘Brain failure’ 
should be awarded similar status as heart failure, respiratory failure 
and renal failure. Delirium is under-recognised. There should be 
greater emphasis on the clinical training of doctors, nurses, carers and 
members of allied health services to effectively screen for delirium 
and ameliorate risk factors. As an important quality indicator, efforts 
Table 1. Characteristics for the overall cohort, stratified by absence/presence of delirium
Characteristics  Overall, N=808 Without delirium, n=709 With delirium, n=99
Age (years), median (IQR) 51 (36 - 65) 50.52 (35 - 65) 54.93 (40 - 70)
Females, n (%) 418 (52) 372 (52) 46 (46)
Education, years (n=765)
Education, median (IQR) 9 (7 - 11) 9 (7 - 11) 9 (7 - 11)
<7, n (%) 167 (22) 150 (22) 17 (23)
Communication barriers, n (%)  
Deafness 12 (1) 8 (1) 4 (4)
Dysphonia 6 (1) 6 (1) 0 (0)
Language barrier 51 (6) 41 (6) 10 (10)
Visual impairment 18 (2) 12 (2) 6 (6)
Dysarthria 36 (4) 27 (4) 9 (9) 
Risk factors for delirium, n (%)†  
Age >70 years 143 (18) 118 (17) 25 (25)
Cognitive impairment 39 (5) 26 (4) 13 (14)*
Terminal illness 23 (3) 14 (2) 9 (9)*
Depression 60 (7) 53 (7) 7 (7)
Indwelling urinary catheter 79 (10) 50 (7) 29 (30)*
Immobility 108 (14) 83 (12) 25 (27)*
Comorbidities, median (IQR) 2 (1 - 3) 2 (1 - 3) 3 (2 - 4)*
>3 comorbidities 355 (44) 300 (42) 55 (56)
Barthel index <50 36 (5) 18 (3) 18 (19)*
Diagnostic category – 4 most frequent categories, n (%) 
Communicable diseases
Pulmonary TB 60 (7) 53 (8) 7 (7)
Respiratory infections 58 (7) 48 (7) 10 (10)
HIV-related infections 24 (3) 20 (3) 4 (4)
GIT infections 23 (3) 20 (3) 3 (3)
Non-communicable diseases
Cardiovascular 170 (21) 160 (23) 10 (10)*
CNS 86 (11) 63 (9) 23 (23)*
Respiratory 76 (9) 75 (11) 1 (1)*
Renal 48 (6) 41 (6) 7 (7)
HIV status
HIV-positive, n (%) 183 (29) 159 (29) 24 (32)
CD4+ (cells/µL), median (IQR) 150 (66 - 312) 155 (66 - 313) 113 (60 - 282)
Chronic medications, n (%)
None 227 (28) 198 (28) 29 (29)
1 - 5 drugs 349 (43) 307 (43) 42 (42)
≥6 drugs 232 (29) 204 (29) 28 (28)
Admission investigations, median (IQR)
Sodium, mmol/L 139 (136 - 142) 139 (136 - 142) 140 (136 - 144)
Potassium, mmol/L 4.63 (4.16 - 5.20) 4.63 (4.20 - 5.18) 4.59 (4.03 - 5.21)
Urea, mmol/L 7.3 (4.9 - 9.3) 7.2 (4.8 - 9.1) 8.3 (6.0 - 15.5)*
Creatinine, µmol/L 85.5 (68.0 - 99.0) 85.0 (67.0 - 98.0) 91.0 (74.0 - 195.0)*
Haemoglobin, g/dL 11.90 (9.70 - 14.10) 11.90 (9.60 - 14.20) 11.20 (9.70 - 13.70)
White cell count, /µL 9.13 (7.40 - 10.07) 9.18 (7.44 - 9.98) 9.03 (7.15 - 11.70)
IQR = interquartile range; TB = tuberculosis; GIT = gastrointestinal; CNS = central nervous system.
*p<0.01; p-values for differences between those with and without delirium were calculated with Fisher’s exact test, χ2 test or Wilcoxon test, as appropriate. No correction for multiple comparisons 
was made.
†Unless otherwise indicated.
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should be made to ensure early detection and management. Research 
into why patients who develop delirium have worse outcomes should 
be explored. 
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